Case Study: Improved Evaluation of Long-Term Safety & Efficacy of Lovotibeglogene Autotemcel Gene Therapy
Time: 11:30 am
day: Day 2- Clinical 1
Details:
• Implementation of extended follow-up periods and comprehensive monitoring to assess the durability of therapeutic effects and identify late-onset adverse events
• Utilization of novel biomarkers and genomic assays to track gene therapy persistence, expression levels, and potential off-target effects over time
• Incorporating patient-reported outcomes and quality-of-life assessments to evaluate the real-world impact and sustained efficacy of the therapy
